Palisade Bio's Meeting Adjourned Due to Lack of Quorum
Palisade Bio, Inc. (NASDAQ: PALI), a clinical-stage biopharmaceutical company, is at a critical moment as its recent special meeting of stockholders was adjourned because there were not enough shareholders present to meet the quorum. This meeting, which took place on a specific day in September, aimed to move forward with important corporate proposals but fell short of the necessary attendance.
Understanding Quorum Requirements
For a corporate meeting to progress, a quorum, defined as one-third of the outstanding shares entitled to vote, must be present. Unfortunately, fewer than this threshold were represented either in person or via proxy during the session. To give shareholders more time to weigh in on the proposals detailed in the documents filed with the SEC, the meeting will be rescheduled.
Next Steps for Stockholders
The reconvened meeting is set for a future date in October, emphasizing the importance of participation from stockholders. In the meantime, Palisade Bio has retained Mediant Communications Inc. to assist in gathering adequate votes, ensuring that more voices are heard in the decision-making process.
Voting Procedures Explained
Only those stockholders who were registered as of a specific date in July have the right to vote. As the original meeting was adjourned, roughly 29.68% of the company's shares had already voted. Proxies cast during the initial gathering will remain valid unless explicitly revoked. Stockholders who have yet to vote are encouraged to submit their votes before a specified deadline in October.
About Palisade Bio
Dedicated to addressing the needs of patients with autoimmune and inflammatory conditions, Palisade Bio seeks to innovate within the biopharmaceutical sector. The company is focused on developing groundbreaking therapies designed to enhance patient outcomes significantly. For additional information on their endeavors, stockholders and interested parties can visit the company’s website directly.
Investor Relations Contact Information
Your inquiries are important: investors can reach out to JTC Team, LLC. For assistance regarding proxies or other voting-related questions, stockholders should feel free to call during business hours. The team is ready to provide the necessary support to ensure all voices are counted.
Frequently Asked Questions
What was the outcome of the recent special meeting of stockholders?
The meeting was adjourned due to a lack of quorum, preventing any business from being conducted.
What is the significance of a quorum?
A quorum is the minimum number of shares required to be present at a meeting to conduct official business and make binding decisions.
How can stockholders participate in the upcoming vote?
Stockholders must vote by the specified deadline in October to ensure their participation in the decision-making process.
Who is assisting Palisade Bio with obtaining votes?
Palisade Bio has engaged Mediant Communications Inc. to help secure the necessary votes for a quorum.
How can stockholders contact the investor relations team?
Investors can reach the JTC Team, LLC via a provided phone number during business hours for any voting-related assistance.
